Fleischmann RM - Search Results

1

Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1).

Chandran V, van der Heijde D, Fleischmann RM, Lespessailles E, Helliwell PS, Kameda H, Burgos-Vargas R, Erickson JS, Rathmann SS, Sprabery AT, Birt JA, Shuler CL, Gallo G. Chandran V, et al. Among authors: fleischmann rm. Rheumatology (Oxford). 2020 Oct 1;59(10):2774-2784. doi: 10.1093/rheumatology/kez684. Rheumatology (Oxford). 2020. PMID: 32031665 Free PMC article. Clinical Trial.

2

Examining the efficacy of biologic therapy: are there real differences?

Fleischmann RM. Fleischmann RM. J Rheumatol Suppl. 2002 Sep;65:27-32. J Rheumatol Suppl. 2002. PMID: 12236619 Review.

3

Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.

Fleischmann RM, Baumgartner SW, Tindall EA, Weaver AL, Moreland LW, Schiff MH, Martin RW, Spencer-Green GT. Fleischmann RM, et al. J Rheumatol. 2003 Apr;30(4):691-6. J Rheumatol. 2003. PMID: 12672185

4

Addressing the safety of anakinra in patients with rheumatoid arthritis.

Fleischmann RM. Fleischmann RM. Rheumatology (Oxford). 2003 May;42 Suppl 2:ii29-35. doi: 10.1093/rheumatology/keg330. Rheumatology (Oxford). 2003. PMID: 12817093 Review.

5

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).

Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, Fischkoff SA, Chartash EK. Furst DE, et al. Among authors: fleischmann rm. J Rheumatol. 2003 Dec;30(12):2563-71. J Rheumatol. 2003. PMID: 14719195 Clinical Trial.

6

Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.

Tesser J, Fleischmann R, Dore R, Bennett R, Solinger A, Joh T, Modafferi D, Schechtman J; 990757 Study Group. Tesser J, et al. J Rheumatol. 2004 Apr;31(4):649-54. J Rheumatol. 2004. PMID: 15088288 Clinical Trial.

7

Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis.

Genovese MC, Bathon JM, Fleischmann RM, Moreland LW, Martin RW, Whitmore JB, Tsuji WH, Leff JA. Genovese MC, et al. Among authors: fleischmann rm. J Rheumatol. 2005 Jul;32(7):1232-42. J Rheumatol. 2005. PMID: 15996057 Clinical Trial.

8

A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis.

Furst DE, Fleischmann R, Kopp E, Schiff M, Edwards C 3rd, Solinger A, Macri M; 990136 Study Group. Furst DE, et al. J Rheumatol. 2005 Dec;32(12):2303-10. J Rheumatol. 2005. PMID: 16331754 Clinical Trial.

9

Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.

Bathon JM, Fleischmann RM, Van der Heijde D, Tesser JR, Peloso PM, Chon Y, White B. Bathon JM, et al. Among authors: fleischmann rm. J Rheumatol. 2006 Feb;33(2):234-43. J Rheumatol. 2006. PMID: 16465653 Clinical Trial.

10

Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis.

Davis JC Jr, van der Heijde DM, Braun J, Dougados M, Clegg DO, Kivitz AJ, Fleischmann RM, Inman RD, Ni L, Lin SL, Tsuji WH. Davis JC Jr, et al. Among authors: fleischmann rm. Ann Rheum Dis. 2008 Mar;67(3):346-52. doi: 10.1136/ard.2007.078139. Epub 2007 Oct 29. Ann Rheum Dis. 2008. PMID: 17967833 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

291 results

Search Page